immune checkpoint inhibitor

You have access
Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic Renal Cell Cancer
SHOTARO YASUOKA, TAKESHI YUASA, RYO FUJIWARA, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, YUKIHIRO KONDO and JUNJI YONESE

Anticancer Research November 2020, 40 (11) 6493-6497; DOI: https://doi.org/10.21873/anticanres.14671
You have access
Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma
CHIHIRO FUSHIMI, ISAKU OKAMOTO, TAKASHI MATSUKI, TATSUO MASUBUCHI, TAKURO OKADA, HIROKI SATO, KIYOAKI TSUKAHARA, TAKAHITO KONDO, TAKU YAMASHITA, KENJI HANYU, GO OMURA, HIDEAKI TAKAHASHI, YUICHIRO TADA and KOUKI MIURA

Anticancer Research September 2020, 40 (9) 5277-5283; DOI: https://doi.org/10.21873/anticanres.14532
You have access
Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer
KUNIHIKO KOBAYASHI, KYOICHI KAIRA and HIROSHI KAGAMU

Anticancer Research September 2020, 40 (9) 5309-5311; DOI: https://doi.org/10.21873/anticanres.14537
You have access
Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor
SOUSUKE KUBO, NOBUAKI KOBAYASHI, KOHEI SOMEKAWA, MOMO HIRATA, CHISATO KAMIMAKI, HIROKO AIKO, SEIGO KATAKURA, SHUHEI TERANISHI, KEISUKE WATANABE, YU HARA, MASAKI YAMAMOTO, MAKOTO KUDO and TAKESHI KANEKO

Anticancer Research July 2020, 40 (7) 3889-3896; DOI: https://doi.org/10.21873/anticanres.14379
You have access
Significance of Quantitative Interferon-gamma Levels in Non-small-cell Lung Cancer Patients' Response to Immune Checkpoint Inhibitors
TOMOHIRO KANAI, HIDEKAZU SUZUKI, HIROKO YOSHIDA, AKANE MATSUSHITA, HIROMI KAWASUMI, YUMIKO SAMEJIMA, YOSHIMI NODA, SHINGO NASU, AYAKO TANAKA, NAOKO MORISHITA, SHOJI HASHIMOTO, KUNIMITSU KAWAHARA, YOSHITAKA TAMURA, NORIO OKAMOTO, TOSHIO TANAKA and TOMONORI HIRASHIMA

Anticancer Research May 2020, 40 (5) 2787-2793; DOI: https://doi.org/10.21873/anticanres.14251
You have access
Efficacy of Cytotoxic Agents After Progression on Anti-PD-(L)1 Antibody for Pre-treated Metastatic Gastric Cancer
KYOKO KATO, YUKIYA NARITA, SEIICHIRO MITANI, KAZUNORI HONDA, TOSHIKI MASUISHI, HIROYA TANIGUCHI, SHIGENORI KADOWAKI, TAKASHI URA, MASASHI ANDO, MASAHIRO TAJIKA and KEI MURO

Anticancer Research April 2020, 40 (4) 2247-2255; DOI: https://doi.org/10.21873/anticanres.14187
You have access
Efficacy of PD-1 Inhibitors in Older Non-small Cell Lung Cancer Patients
YUKIKO NAKAMURA, KAZUHITO MIYAZAKI, NAOTO AIKO, YUKI MISUMI, YOKO AGEMI, YURI TANIGUCHI, MARI ISHI, TSUNEO SHIMOKAWA, HIROAKI OKAMOTO and TAKEHARU YAMANAKA

Anticancer Research February 2020, 40 (2) 923-928; DOI: https://doi.org/10.21873/anticanres.14025
You have access
The Impact of Antibiotics on Prognosis of Metastatic Renal Cell Carcinoma in Japanese Patients Treated With Immune Checkpoint Inhibitors
KOSUKE UEDA, SATORU YONEKURA, NAOYUKI OGASAWARA, YOSHIHIRO MATSUNAGA, RYUJI HOSHINO, HIROFUMI KUROSE, KATSUAKI CHIKUI, KEIICHIRO UEMURA, MAKOTO NAKIRI, KIYOAKI NISHIHARA, MITSUNORI MATSUO, SHIGETAKA SUEKANE and TSUKASA IGAWA

Anticancer Research November 2019, 39 (11) 6265-6271; DOI: https://doi.org/10.21873/anticanres.13836
You have access
Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors
KIYOHIRO ANDO, KAZUYUKI HAMADA, MAKOTO WATANABE, RYOTARO OHKUMA, MIDORI SHIDA, RIE ONOUE, YUTARO KUBOTA, HIROTO MATSUI, TOMOYUKI ISHIGURO, YUYA HIRASAWA, HIROTSUGU ARIIZUMI, JUNJI TSURUTANI, KIYOSHI YOSHIMURA, TAKUYA TSUNODA, SHINICHI KOBAYASHI and SATOSHI WADA

Anticancer Research September 2019, 39 (9) 5195-5201; DOI: https://doi.org/10.21873/anticanres.13716
You have access
Usefulness of the nCounter Analysis System to Monitor Immune-related Biomarkers in PBMCs During Anti-PD-1 Therapy
TAKAFUMI MORISAKI, MAKOTO KUBO, MASAYO UMEBAYASHI, YUAN YUAN, AKIHIRO TSUYADA, HIROTO TANAKA, NORIHIRO KOYA, SHINICHIROU NAKAGAWA, TAKASHI MORISAKI and MASAFUMI NAKAMURA

Anticancer Research August 2019, 39 (8) 4517-4523; DOI: https://doi.org/10.21873/anticanres.13628

Main menu

User menu

Search

immune checkpoint inhibitor

Pages